Latest Announcements

Mold-Tek Packaging Limited has informed the Exchange about Book Closure and Record date for Final Dividend 2025-26. The Register of Members and Share Transfer Books will remain closed from September 15 to September 21 for the 29th Annual General Meeting and determining the entitlement of the Members for the final dividend.

Jubilant Ingrevia Limited has held its 7th Annual General Meeting (AGM) on August 26, 2026, where all resolutions were passed with the requisite majority. The meeting was conducted through video conferencing, and 82 members attended. The company has made available the proceedings, voting results, and scrutinizer's report on its website and with the National Securities Depositories Limited.

Time Technoplast Limited has received in-principle approval for the merger of its subsidiary company TPL Plastech Limited with the holding company, subject to further approvals. The merger aims to secure the long-term interests of all stakeholders and facilitate consolidation of the group structure.

BlackBuck Limited has informed the Exchange about sending a letter to shareholders who have not registered their email address, providing a web-link to access the Notice and Annual Report for the financial year 2025-26.

Mukta Arts Limited has received a Show Cause Notice (SCN) from the office of the Commissioner of CGST and Central Excise, Vadodara Zone, under section 74 of the CGST Act, 2017. The SCN was received via email on 24th August, 2026, and the Company is seeking expert advice to contest the SCN and will submit its response accordingly.

Hindustan Copper Limited has been fined by BSE and NSE for non-compliance with corporate governance requirements. The company has been asked to appoint required number of directors on its board and has sought waiver of fines from both exchanges.

Cohance Lifesciences Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, as per SEBI regulations.

Cohance Lifesciences Limited has informed the Exchange about Integrated Annual Report 2026, which includes the company's financial performance, business responsibility, and sustainability report for the FY 2025-26.

Mold-Tek Technologies Limited has informed the Exchange that the Board of Directors have recommended a final dividend of Rs. 2 per share for the financial year March 31, 2026, and also approved the issuance of bonus shares in the ratio 1:1.

Oil & Natural Gas Corporation Limited has received notices from BSE and NSE for non-compliance under SEBI (LODR) Regulations, 2015, levying a fine of ₹14,31,340/- each. The non-compliance is related to the composition of the Board, Quorum of Board Meeting, and Composition of Committees. The company has become compliant with respect to the composition of the Stakeholder Relationship Committee and Risk Management Committee with effect from 19.08.2026.

Mold-Tek Packaging Limited has informed the Exchange that the Board of Directors have recommended the Final Dividend of Rs. 3 per share and approved the issue of Bonus Shares in the ratio 1:1, increase in authorized share capital, appointment of Whole Time Director and Non-Executive Independent Director, and change in designation of two directors.

Mold-Tek Technologies Limited has informed the Exchange about the 42nd AGM of the Company, which is scheduled to be held on Monday, September 21, 2026. The Board of Directors has approved the issuance of Bonus Shares in the ratio 1:1, recommending a final dividend of ₹ 2.00/- per equity share for the financial year March 31, 2026, and fixing the Annual General Meeting on September 21, 2026.

Mold-Tek Packaging Limited has informed the Exchange about the outcome of its Board Meeting held on August 26, 2026. The Board has approved the issue of bonus shares in the ratio 1:1, recommended payment of a final dividend of ₹ 3/- per equity share, increased the authorized share capital, and appointed two new directors.

Welspun Investments and Commercials Limited has informed the Exchange about General Updates

OnEMI Technology Solutions Limited has informed the Exchange about convening of the 10th Annual General Meeting of the Company on September 22, 2026, and alteration of the main object clause of Memorandum of Association to provide clarity and flexibility to undertake activities relating to technology platforms and allied services in the financial services ecosystem.

Ratnaveer Precision Engineering Limited has informed the Exchange about Letter of Offer for Right Issue. The company will issue up to 1,24,99,669 fully paid-up equity shares at ₹264 per share, aggregating to ₹329.99 crores, to eligible equity shareholders in the ratio of 7:40.

TPL Plastech Limited has informed the Exchange about General Updates, including in-principle approval for merger with Time Technoplast Limited, appointment of Chief Financial Officer, and resignation of Chief Financial Officer.

Senores Pharmaceuticals Limited has announced the approval of various matters at its Board Meeting held on August 26, 2026, including the appointment of a Company Secretary and Compliance Officer, a Non-Executive Additional Director, and authorized officers for determining materiality of events and disclosures. The company has also approved the adoption of the Senores Pharmaceuticals Employee Stock Option Scheme 2026 and proposed the incorporation of Wholly Owned Subsidiaries in Mexico and Canada.

Senores Pharmaceuticals Limited has announced the outcome of its Board Meeting held on August 26, 2026, where it approved several key decisions, including the appointment of a Company Secretary and Compliance Officer, a Non-Executive Additional Director, and authorized officers to determine materiality of events or information. The company also approved the adoption of the Senores Pharmaceuticals Employee Stock Option Scheme 2026 and proposed the incorporation of Wholly Owned Subsidiaries in Mexico and Canada to support its business and strategic objectives.

Senores Pharmaceuticals Limited has announced the outcome of its Board Meeting held on August 26, 2026, where it approved several key decisions, including the appointment of a Company Secretary and Compliance Officer, a Non-Executive Additional Director, and authorized officers to determine materiality of events or information. The company also approved the adoption of the Senores Pharmaceuticals Employee Stock Option Scheme 2026 and proposed the incorporation of a Subsidiary Company in Canada to support its business and strategic objectives in the Canadian and other international markets.